SARS-CoV-2(14) COVID-19(13) Vaccine(11) exhibited(10) clinical trials(7) host cells(5) COVID-19 patients(5) first dose(5) RNA(5) BNT162b2 vaccines(5) permeation(5) Pfizer(5) bind(5) form(5) phase 2/ 3 trials(5) BNT162b2 vaccine(5) receive(5) clinical(5) Pfizer-BioNTech(5) Bicelles(5) Immunity(5) antiviral therapy(5) operation(5) adolescents(5) Support(5) Phosphatidylcholine(5) EUA(5) participant(5) TEM(5) BNT162b2(5)